The fight against cancer is global. Our focus must be as well.

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Dear Colleagues,

Today, our world is small. It feels smaller all the time. In a few hours we can get to any point on the globe. 

We routinely attend meetings where one or more people are in Europe, the Middle East, or Africa, joining remotely. In the cancer community, it is rare not to have friends and collaborators who are all over the world, and that is one of the truly special parts of this career.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
W. Kimryn Rathmell, MD, PhD, MMHC
Former director, National Cancer Institute
Table of Contents

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
W. Kimryn Rathmell, MD, PhD, MMHC
Former director, National Cancer Institute

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login